IDEXX LABORATORIES INC /DE Total Contract Liability
IDEXX LABORATORIES INC /DE (IDXX) had Total Contract Liability of $101.99 million as of 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2019-02-15
- 2018-12-31: Contract with Customer, Liability $101.99M.
- 2018-09-30: Contract with Customer, Liability $103.70M.
- 2018-01-01: Contract with Customer, Liability $110.16M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2018-12-31 | $101.99M 10-K · filed 2019-02-15 |
| 2018-09-30 | $103.70M 10-Q · filed 2018-11-01 |
| 2018-01-01 | $110.16M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |